Article Text

Download PDFPDF

Barriers to implementation of stratified care in primary biliary cholangitis: a scoping exercise
  1. Margaret Corrigan1,2,
  2. Gideon Hirschfield1,2,
  3. Sheila Greenfield3,
  4. Jayne Parry3
  1. 1University of Birmingham, NIHR Birmingham Biomedical Research Centre, Centre for Liver Research, Birmingham, UK
  2. 2Department of Liver medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  3. 3University of Birmingham, Institute of Applied Health Research, Birmingham, UK
  1. Correspondence to Dr Margaret Corrigan; m.corrigan{at}bham.ac.uk

Abstract

Patients with primary biliary cholangitis (PBC) can be stratified into low-risk and high-risk groups based on their response to treatment. Newly published guidelines from the British Society of Gastroenterology suggest low-risk patients can be managed substantially in primary care. This represents a shift from existing practice and makes assumptions about service capacity and the willingness of both patients and health care practitioners (HCPs) to make this change. The aim of this paper is to identify possible barriers to the implementation of these new care pathways through review of the PBC-specific literature and by identifying the experiences of patients and HCPs managing a different condition with comparable patients and disease characteristics. Searches of MEDLINE, CINAHL and EMBASE were undertaken. Within the existing PBC literature there is little data surrounding stakeholder perspectives on place of care. Review of the breast cancer literature highlights a number of barriers to change including primary care practitioner knowledge and work load, communication between healthcare settings, and the significance of the established doctor–patient relationship. Further research is needed to establish the extent to which these barriers may surface when changing PBC care pathways, and the actions required to overcome them.

  • primary biliary cirrhosis
  • primary care
  • health service research
  • cholestatic liver diseases

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MC contributed to the conception and design of this scoping review, the acquisition and analysis of the data, and drafted and revised the paper for final submission. GH, SG and JP contributed to conception and design and revised the draft paper for final submission. MC acts as the guarantor for this submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests MC and GH are collaborating investigators for UK-PBC, a MC stratified medicine platform. SG and JP declare no competing interests.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement No additional data are available.